Skip to main content
Equibles

Dr. Nataliya Agafonova M.D.

Longeveron Inc. (LGVN)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dr. Nataliya Agafonova M.D.

Longeveron Inc. reported in an 8-K filed July 5, 2023 that Dr. Nataliya Agafonova M.D. was appointed Chief Medical Officer, effective July 1, 2023. Dr. Nataliya Agafonova M.D. has spoken on 1 earnings call across 1 company, most recently for Longeveron Inc. on August 12, 2026.

“Longeveron Inc. (“Longeveron” or the “Company”) has announced the appointment of Dr. Nataliya Agafonova M.D. to the Longeveron executive leadership team in the role of Chief Medical Officer (“CMO”), effective July 1, 2023.”
Longeveron Inc. Form 8-K, filed July 5, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Longeveron Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.